Delivery Order SPE2DB22D1052-SPE2DB25FV0CV
Award Date 9/19/25
Potential Completion Date 9/22/25
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,463.51 delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of UBRELVY 100 MG tablets (unit dose, 10-count packages). This firm fixed price delivery order, which is not set-aside designated, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a $3,188.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 MG tablets (16 unit dose packages) on September 8, 2025, with a completion date of September 9, 2025. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $2,126.74 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (16 unit dose tablets) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price contract, which is not set-aside, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and running through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for UBRELVY (migraine treatment) 100 mg tablets in unit dose packages of 10, valued at $1,902.35 under a firm fixed price contract. This award, issued on September 17, 2025, with completion scheduled for September 18, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania facility. The delivery order is a child contract executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of UBRELVY 50 mg tablets (10-count unit dose packaging) with a ceiling value of $4,919.80 and an ultimate completion date of August 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of UBRELVY 100 MG tablets in unit dose packaging (10 tablets per unit). This competitively awarded, firm fixed-price delivery order has a ceiling value of $6,583.77 and an ultimate completion date of September 17, 2025. The contract is issued without a set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of UBRELVY 50 mg tablets in unit-dose packaging of 10s. This competitively awarded contract, valued at $9,038.71, carries a firm fixed price and is scheduled for completion by September 17, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,412.22 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (16-count unit dose packaging) on September 16, 2025, with completion targeted for September 17, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 15, 2025, for UBRELVY 100 MG tablets (10-unit dose packaging) with a ceiling value of $1,146.60. This competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $3,420.49 to AmerisourceBergen Drug Corp for the supply of UBRELVY (an FDA-approved migraine treatment) in 100 mg tablet form on August 20, 2025, with completion expected by August 21, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...